Ribault M, Chapelon J Y, Cathignol D, Gelet A
INSERM U281, Lyon, France.
Ultrason Imaging. 1998 Jul;20(3):160-77. doi: 10.1177/016173469802000302.
High intensity focused ultrasound (HIFU) is an effective technique for creating coagulative necrotic lesions in biological tissue, with a view to treating localized tumors. Although good results have already been obtained, notably in urology, current systems lack a real time monitoring system to check the efficacy of the treatment procedures. This study describes the development and assessment of a noninvasive system for making local measurements of attentuation variations during HIFU treatment procedures. An apparatus (Ablatherm, Edap-Technomed, France), combining a 2.5 MHz therapeutic transducer and a 5.5 MHz twin plane imaging probe (connected to an ultrasound scanner), was used to produce lesions. The rf signals needed to calculate the attenuation were recorded as outputs from the ultrasound scanner, before and after the high intensity firing sequences, which were performed on ten pieces of porcine liver. Each firing sequence involved producing a lesion volume comprising 42 individual lesions. A number of recordings were also made without producing lesions, in order to test the reproducibility of the measurements. The attenuation function was evaluated locally using the centroid and the multinarrowband methods. Initially, changes in the integrated attenuation alpha (mean attenuation in the 4-7 MHz range) and the attenuation slope beta were examined for the lesion volume. beta values did not vary significantly within this range, whereas alpha values varied significantly (in the region of 86% of the initial level) in comparison to measurements performed without forming lesions. The differential attenuation delta alpha (representing local variations in alpha) was subsequently used to generate images revealing the lesion areas. There was a strong similarity between these 'delta alpha images' and the lesion volumes defined by the operator. 'delta alpha images' offer several advantages over existing attenuation imaging techniques. Any problems related to the heterogeneity of the medium are eliminated, since only the change in attenuation is taken into account. Furthermore, there is no need to compensate for diffraction when estimating delta alpha, as the rf signals are captured in exactly the same positions before and after treatment. This technique can be used during in vivo treatment procedures. It can be implemented in real time, since the computational algorithms (based primarily on FFT calculations) are very fast. The technique should provide clinical practitioners with valuable qualitative and quantitative information for use in HIFU ultrasound surgery.
高强度聚焦超声(HIFU)是一种在生物组织中创建凝固性坏死病灶的有效技术,旨在治疗局部肿瘤。尽管已经取得了良好的效果,尤其是在泌尿外科领域,但目前的系统缺乏实时监测系统来检查治疗程序的效果。本研究描述了一种用于在HIFU治疗过程中进行局部衰减变化测量的非侵入性系统的开发和评估。使用一种装置(Ablatherm,法国Edap-Technomed公司),该装置结合了一个2.5MHz的治疗换能器和一个5.5MHz的双平面成像探头(连接到超声扫描仪)来产生病灶。在高强度发射序列前后,将计算衰减所需的射频信号作为超声扫描仪的输出进行记录,这些序列在十块猪肝上进行。每个发射序列包括产生一个由42个单独病灶组成的病灶体积。还进行了一些不产生病灶的记录,以测试测量的可重复性。使用质心和多窄带方法在局部评估衰减函数。最初,检查病灶体积的积分衰减α(4-7MHz范围内的平均衰减)和衰减斜率β的变化。在此范围内,β值没有显著变化,而与未形成病灶时的测量相比,α值有显著变化(在初始水平的86%左右)。随后使用差分衰减δα(表示α的局部变化)来生成显示病灶区域的图像。这些“δα图像”与操作员定义的病灶体积之间有很强的相似性。“δα图像”比现有的衰减成像技术具有几个优点。由于只考虑衰减的变化,与介质不均匀性相关 的任何问题都被消除了。此外,在估计δα时不需要补偿衍射,因为在治疗前后在完全相同的位置捕获射频信号。该技术可用于体内治疗过程。由于计算算法(主要基于快速傅里叶变换计算)非常快,因此可以实时实现。该技术应为临床医生提供用于HIFU超声手术的有价值的定性和定量信息。